Human Microbiome Market: Rising Prevalence of Gastrointestinal and Metabolic Disorders Drive Market Growth

Wilmington, Delaware, United States, Transparency Market Research Inc.: Microbiome is a genetic component of various microorganisms such as bacteria, fungi, protozoa, and viruses, which live inside and on the human body. The rising knowledge about the benefits of the bacteria present in the microbiome for better digestion of food, regulation of the immune system, and protection against other disease-causing bacteria is fueling the growth of the global human microbiome market. Manufacturers operating in the global human microbiome market are developing diagnostic and therapeutic products. The increasing research & development activities in the field of human microbiome market is contributing to the growth of the global human microbiome market.

Human Microbiome Market Outlook 2028

  • The global human microbiome market was valued at US$ 1.3 Bn in 2020
  • It is estimated to expand at a CAGR of 7.1% from 2021 to 2028
  • The global human microbiome market is expected to reach the value of US$ 2.2 Bn by the end of 2028

Request Sample of Report -

Human Microbiome Market: Overview

According to Transparency Market Research’s latest report on the global human microbiome market for the historical period 2017–2019 and forecast period 2021–2028, technological advancements, mergers & collaborations, rise in venture capital investments, and surge in financing of the microbiome projects are projected to drive the global human microbiome market during the forecast period

Increase in Industry-Institute Partnerships and High Unmet Medical Needs to Drive Global Market

Significant number of microbiome therapeutics and diagnostics are targeted toward a market with large unmet medical needs. For instance, the present standard of care for Clostridium difficile infection (CDI) is a treatment with antibiotics. Antibiotic treatment can resolve acute infection; however, it also has the probability to worsen dysbiosis in patients.

Request Brochure of Report -

This makes them potentially more susceptible to recurrence of CDI. Patients with recurrent CDI receive many rounds of antibiotics that could worsen dysbiosis, and hence, are more likely to face a relapse. Various key companies strives to resolve unmet medical needs for cancer, CNS disorders, women’s health disorders, skin disorders, and rare diseases through their microbiome-based products.

The human microbiome is still an emerging and extensive science. Collaborating with eminent scientists, researchers, and physicians in the field helps in enhancing a company’s go-to-market strategy. Industry-institute partnerships are thriving in the microbiome market and fueling growth. For instance, in 2020, Enterome collaborated with BIOASTER Institute to explore the mechanism of cancer immunotherapies that are microbiome derived.

Get COVID-19 Analysis on Human Microbiome Market -

Clinical Trial Setbacks, Regulatory Hurdles, and Privacy Issues in Diagnostics to Hamper Market

The global microbiome market is in its nascent stage. Hence, the likelihood of unfavorable results from a clinical trial is a risk that could hamper market growth. For instance, in 2016, Seres Therapeutics suffered a setback as its microbiome therapeutic SER-109 failed to overtake a placebo for reducing the risk of Clostridium difficile infection (CDI). However, the company is backed by a strong research team and aims to find a solution to the hurdle soon. Therefore, despite minor setbacks, expertise and advances in the microbiome market can help to offset the restraint.

Concerns over privacy of subjects and sending stool or other samples for diagnostic testing are likely to restrain the global market. To draw an analogy, it is similar to the concern over 23andme’s genetic tests, where there were concerns in public regarding privacy and anonymity of their genetic data.

Make an Enquiry Before Buying -

Human Microbiome Market: Competition Landscape

This report profiles major players in the global human microbiome market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global human microbiome market is highly fragmented, with the presence of a number of small, mid-size, and large prominent players

Leading players operating in the global human microbiome market are

  • AOBiome
  • Enterome Biosciences SA
  • Metabiomics Corp. (BioSpherex LLC)
  • Microbiome Therapeutics LLC
  • Osel, Inc.
  • Rebiotix, Inc.
  • Second Genome
  • Seres Therapeutics
  • Synthetic Biologics, Inc.
  • Vedanta Biosciences
  • 4D Pharma
  • Ferring Pharmaceuticals, and other prominent players

More Trending Reports by Transparency Market Research –

Neurotrophic Keratitis Market:

E. Coli Testing Market:

Cardiac Pacemakers Market:

Hospital acquired disease testing Market:

Single-use Bioprocessing Systems Market:

Diagnostic Specialty Antibodies Market:

Biotherapeutics Cell Line Development Market:

Genome Engineering Market:

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update -


Rohit Bhisey
Transparency Market Research Inc.
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

Back to news